SEO URLwww.firestrike.ai/deals/ptc-therapeutics-jefferies-acquisition-2026
acquisitionAnnounced · Mar 9, 2026biopharmaceuticalSource · Community DiscussionsArticle · Factual
Jefferies acquires PTC Therapeutics
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$97.2M
Target
PTC Therapeutics
NASDAQ: PTCT · Warren, New Jersey
Acquirer
Jefferies
Financial Stake
Status
Completed
Jefferies agreed to acquire PTC Therapeutics. Reported deal value: $97.2M. Status: Completed. Sector: biopharmaceutical. Target headquarters context: Warren, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-03-09. Figures and status may change as filings and press coverage update.
› Jefferies Financial Group Inc. has acquired a new stake in PTC Therapeutics , Inc. , purchasing 1,584,678 shares of the biopharmaceutical company stock during the third quarter
Deal timeline
Announced
Mar 9, 2026 · nationaltoday.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharmaceutical with a reported deal value of $97.2M. Figures and status may change as sources update.
Sources: nationaltoday.com · Primary article · FireStrike proprietary index